Literature DB >> 17548587

TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.

Laura S Treml1, Gianluca Carlesso, Kristen L Hoek, Jason E Stadanlick, Taku Kambayashi, Richard J Bram, Michael P Cancro, Wasif N Khan.   

Abstract

Through their differential interactions with B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), the three BLyS family receptors play central roles in B cell survival and differentiation. Recent evidence indicates BLyS receptor levels shift following BCR ligation, suggesting that activation cues can alter overall BLyS receptor profiles and thus ligand sensitivity. In this study, we show that TLR stimuli also alter BLyS receptor expression, but in contrast to BCR ligation, TLR9 and TLR4 signals, preferentially increase transmembrane activator calcium modulator and cyclophilin ligand interactor (TACI) expression. Although both of these TLRs act through MyD88-dependent mechanisms to increase TACI expression, they differ in terms of their downstream mediators and the B cell subset affected. Surprisingly, only TLR4 relies on c-Rel and p50 to augment TACI expression, whereas TLR9 does not. Furthermore, although all follicular and marginal zone B cells up-regulate TACI in response to TLR9 stimulation, only marginal zone B cells and a subset of follicular B cells respond to TLR4. Finally, we find that both BLyS and APRIL enhance viability among quiescent and BCR-stimulated B cells. However, although BLyS enhances viability among TLR stimulated B cells, APRIL does not, suggesting that TACI but not BLyS receptor 3 may share survival promoting pathways with TLRs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548587     DOI: 10.4049/jimmunol.178.12.7531

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses.

Authors:  Sreemanti Basu; Avijit Ray; Bonnie N Dittel
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

2.  Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract.

Authors:  Cordelia Manickam; Chiadika Nwanze; Daniel R Ram; Spandan V Shah; Scott Smith; Rhianna Jones; Brady Hueber; Kyle Kroll; Valerie Varner; Paul Goepfert; Stephanie Jost; R Keith Reeves
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

Review 3.  The rationale for BAFF inhibition in systemic lupus erythematosus.

Authors:  Anne Davidson
Journal:  Curr Rheumatol Rep       Date:  2012-08       Impact factor: 4.592

Review 4.  BAFF and selection of autoreactive B cells.

Authors:  Zheng Liu; Anne Davidson
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

Review 5.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

Review 6.  Homeostatic control of B lymphocyte subsets.

Authors:  Jenni E Crowley; Jean L Scholz; William J Quinn; Jason E Stadanlick; John F Treml; Laura S Treml; Yi Hao; Radhika Goenka; Patrick J O'Neill; Andrew H Matthews; Ronald F Parsons; Michael P Cancro
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

7.  Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI.

Authors:  Gregory S Dickinson; Guizhi Sun; Richard J Bram; Kishore R Alugupalli
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

8.  Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.

Authors:  Weifeng Xu; Paul A Santini; Allysia J Matthews; April Chiu; Alessandro Plebani; Bing He; Kang Chen; Andrea Cerutti
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.

Authors:  Tanvi Arkatkar; Holly M Jacobs; Samuel W Du; Quan-Zhen Li; Kelly L Hudkins; Charles E Alpers; David J Rawlings; Shaun W Jackson
Journal:  Kidney Int       Date:  2018-06-12       Impact factor: 10.612

10.  The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.

Authors:  John J Lee; Ingrid Rauter; Lilit Garibyan; Esra Ozcan; Tatyana Sannikova; Stacey R Dillon; Anthony C Cruz; Richard M Siegel; Richard Bram; Haifa Jabara; Raif S Geha
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.